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The absorption of zwitterionic imino and amino acids, and related drugs, is an essential function of the small intestinal epithelium. This review
focuses on the physiological roles of transporters recently identified at the molecular level, in particular SLC36A1, by identifying how they relate
to the classical epithelial imino and amino acid transporters characterised in mammalian small intestine in the 1960s–1990s. SLC36A1 transports
a number of D- and L-imino and amino acids, β- and γ-amino acids and orally-active neuromodulatory and antibacterial agents. SLC36A1 (or
PAT1) functions as a proton-coupled imino and amino acid symporter in cooperation with the Na+/H+ exchanger NHE3 (SLC9A3) to produce the
imino acid carrier identified in rat small intestine in the 1960s but subsequently ignored because of confusion with the IMINO transporter.
However, it is the sodium/imino and amino acid cotransporter SLC6A20 which corresponds to the betaine carrier (identified in hamster, 1960s)
and IMINO transporter (identified in rabbit and guinea pig, 1980s). This review summarises evidence for expression of SLC36A1 and SLC6A20
in human small intestine, highlights the differences in functional characteristics of the imino acid carrier and IMINO transporter, and explains the
confusion surrounding these two distinct transport systems.
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amino acid absorption through the 20th century
The study of intestinal amino acid absorption has been
constrained by dogma, of one sort or another, for much of the
last 100 years. The first half of the 20th Century was dominated
by the view that amino acid absorption from the gut was a
purely passive or diffusive process (for review see Wiseman
[1]). However, as long ago as 1937, Höber and Höber
demonstrated that the percentage absorption of amino acids
such as glycine and alanine from the rat small intestine was
greatest at low concentrations suggesting a saturable process
[2]. They called this saturable process an accelerating factor
[2]. [Please note that throughout this review the names given to
the various transport systems, as characterised functionally in
epithelial tissues, are highlighted in italics]. In the early 1950s,
Wiseman [3] demonstrated that the absorption of neutral or
zwitterionic (dipolar) amino acids by the rat small intestine in
vitro was active in the sense that, when a racemic mixture of
amino acids was placed in equal concentrations on either side of
the intestine, the L-enantiomer was transported in the absorptive
direction against a concentration gradient. Agar et al. [4]
demonstrated that the absorptive movement of L-histidine
across rat jejunum in vitro was active as it was inhibited by
the metabolic inhibitors cyanide and dinitrophenol. Thus in
1955, Wiseman [5] concluded that a single common special
mechanism was responsible for the absorption of L-forms of
neutral amino acids and that this mechanism excluded D-forms.
When the literature on intestinal amino acid absorption was
reviewed in 1968 (including studies published up to 1965) [1]
the prevailing view that L-, but not D-, amino acids were
transported by active or uphill transport had changed little
except that four distinct pathways for neutral amino acids had
been classified thus superseding the proposal that absorption
was via a single common mechanism.
The earliest evidence for a role of extracellular Na+ in
intestinal transport of neutral amino acids demonstrated that
transport of monoiodotyrosine [6], tyrosine and phenylalanine[7] were reduced when extracellular Na+ was replaced either by
K+ or Li+. Christensen and colleagues [8] had earlier suggested
that glycine uptake in Ehrlich mouse ascites carcinoma cells
could occur in the form of a complex between the carrier,
glycine and the sodium ion and that uptake “could be wholly
driven by the energy inherent in the asymmetry of cellular alkali
metal distribution”. Thus the Na+ gradient hypothesis, which
was originally proposed to account for the uphill accumulation
of sugars, was extended so that Na+ movement down its
concentration gradient was considered the driving force for the
active uphill accumulation of solutes such as amino acids [9–
11]. In 1967, Curran, Schultz and colleagues [12,13] measured
unidirectional Na+ and alanine influx across the mucosal
surface of rabbit ileum and provided the first clear demonstra-
tion of coupled intestinal uptake of amino acid and Na+. In
1975, following the advent of brush-border membrane vesicle
(BBMV) technology, the luminal localisation of a Na+/amino
acid cotransporter was demonstrated unequivocally by mea-
surement of a Na+-dependent L-alanine overshoot in BBMV
prepared from rat small intestine [14].
Thus, by the mid 1960s, the principle that neutral amino acid
transport across the luminal membrane of the small intestinal
epithelium was limited to uptake of L-amino acids via Na+-
coupled cotransporters was firmly established. Unfortunately,
this canon has remained embodied in most reviews of amino
acid transport and in almost all current textbooks of physiology.
We say, unfortunately, because although the Na+ gradient
hypothesis is as applicable today as it was in the 1960s to
describe movement through many transporters of neutral amino
acids there has, for many years, been a large body of evidence to
suggest that other amino acids (e.g. D-amino acids) are absorbed
by concentrative or uphill transport mechanisms and that these
mechanisms may not be linked directly to Na+ cotransport.
Despite H+-coupled amino acid transport being widespread
in plants, fungi and bacteria [15–18] there has been relatively
little evidence for such a coupling in mammalian tissues. A role
for the H+-electrochemical gradient as a driving force in dipolar
amino acid transport across the mammalian small intestinal wall
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mode of transport has generally been in the minority despite
compelling evidence for the existence of the so called “acid
microclimate” (an area of low pH approximately pH 6.1–6.8) at
the luminal surface of the mammalian small intestine [20,21].
The purpose of this review is to encapsulate the evidence
from the 1950s to the present date for the existence of a
transport system which fits neither the substrate selectivity nor
ion-coupling of the dogma describing neutral amino acid
transport across the luminal surface of the mammalian small
intestine: in other words we will summarise here the evidence
for a H+-coupled transporter of L- and D-zwitterionic amino and
imino acids. This transport system is known currently as PAT1
(or proton-coupled amino acid transporter 1) or SLC36A1
(which is the first member of solute carrier family 36) [22–26].
In addition we will explain the reasons for the lack of clarity in
the literature relating to the intestinal absorption of neutral
amino and imino acids which should help to eliminate
confusion in this research field in the future.
2. The 1950s–1960s: transport of D-amino acids
The first dogma to be addressed here is the belief, which
originated in the 1950s, that only L-enantiomers of amino acids
are absorbed from the small intestine. Contrary to this view, the
majority of pre-1950 studies suggested that both L- and D-forms
of amino acids were absorbed at similar rates (for review see
Wiseman [1]). However, when the literature was reviewed in the
late 1960s those earlier studies (pre-1950) were dismissed as
being unreliable due to the methodologies used [1]. This may or
may not have been a reasonable assumption to make. Here we
will focus on the evidence produced in the post-1950 literature.
The initial evidence for “absorption” came from measurements
of the rate of disappearance of a range of amino acids from the
intestinal lumen of the rat ileum in vivo [27]. Amino acids were
presented as racemic mixtures and in each case the disappear-
ance of the L-form was more rapid than the D-form. No
measurements were made of the transported material (either that
taken up into the mucosa or that passing into the serosal
compartment). Unfortunately, the L- and D-forms of any
particular amino acid were never examined separately so it
was not possible to discount competition for a single transport
site with greater affinity for L-amino acids. Similar observations
were made in human ileum (in vivo) [28] where disappearance
of the L-amino acids from a racemic mixture was more rapid
than the D-amino acids. Wiseman [3] also compared L- and D-
amino acid movement across rat small intestine in vitro where
an increase in the appearance of L-amino acids in the serosal
solutions matched the decrease observed in the luminal
solutions. No such change was observed with the D-amino
acids although only racemic mixtures were used (see above). A
consistent observation can be made from these three studies
[3,27,28], that is, the ability of the apparent transport site to
distinguish between stereoisomers varies depending upon the
amino acid under investigation suggesting that not all D-amino
acids are excluded to the same degree. From studies where L-
and D-amino acids were investigated independently, and thenature of the material crossing the intestinal wall determined,
the difference between “absorption” of L- and D-amino acids
becomes less marked. Matthews and Smyth [29] found that
when a racemic mixture of alanine was added to the small
intestine of the cat more L-alanine than D-alanine appeared in
the portal blood. However, D-alanine was absorbed as indicated
by its appearance in the blood (although very high luminal
concentrations were used). In the same study [29], D-alanine
transfer across the mucosal wall was detected in vitro and the
transfer at 37 °C was 4-fold greater than at 18 °C suggesting
non-passive movement. Smyth and Taylor [30] used an in vitro
preparation of rat small intestine and compared material in
mucosal and serosal solutions after a 1 h incubation. L-Alanine
was accumulated in the serosal solution 4-fold above luminal
levels whereas the concentration of D-alanine was similar in
both luminal and serosal solutions suggesting that D-alanine
was absorbed but at a lower rate than L-alanine. Importantly the
rate of transepithelial transfer of D-alanine was greater than a
number of solutes (urea, ascorbic acid and fructose) now
recognised to undergo carrier-mediated transport across the
small intestinal wall. Jervis and Smyth [31] measured
disappearance of amino acids from rat small intestine and
found that when introduced separately L-histidine was absorbed
9.9-fold greater than D-histidine. In contrast, although L-
methionine was absorbed as rapidly as L-histidine it was
absorbed only 1.5-fold greater than D-methionine suggesting
that some D-amino acids were absorbed more rapidly than
others. Furthermore, cross-competition between the D- and L-
amino acids led to the conclusion that the movement of D-amino
acids must involve processes other than passive diffusion [31].
The same authors [32] later demonstrated that D-methionine
was transported across the rat intestine in vitro against a
concentration gradient and this transfer was inhibited by
metabolic inhibitors and L-methionine. These observations
[32] forced a reinterpretation of Wiseman's studies [1,3,5,27]
and suggested that D-methionine transport had not been
observed earlier because of the presence of L-methionine in
the racemic mixture. Jervis and Smyth [32] concluded, there-
fore, that Wiseman's common mechanism was not absolutely
stereospecific although active transfer of D-methionine would
not necessarily mean that all D-amino acids were transported
actively [32]. Similarly Finch and Hird [33] found that D-
alanine uptake (over 4 min) into rat small intestinal segments
was via a rapid and saturable process (following Michaelis–
Menten kinetics) when uptake was compared at 1 and 10 mM.
In addition, D-Serine was concentrated in the serosal solution 2-
fold above luminal levels when measurements were made using
everted sacs of rat small intestine [34,35].
Thus, the view that only L-amino acids were absorbed across
the intestinal wall was only really valid for the period between
1951 and 1959. It is probably correct to conclude that most L-
amino acids are absorbed more rapidly than most D-amino acids
but, in the absence of a detailed study where all amino acids
were investigated individually and evidence for cross-competi-
tion determined, the theory that all D-amino acids are excluded
from any transport site should not have been made quite so
forcefully. In addition, a greater rate of absorption of any
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have led to the conclusion that D-amino acids were not absorbed
at all. It is clear that as long ago as 1959 there were serious
doubts about this concept and by 1964 there was enough
evidence to suggest that D-serine, D-alanine and D-methionine
were absorbed. It should be noted, as will be discussed below,
that both D-serine and D-alanine are substrates for PAT1
(SLC36A1) [22,23,26].
3. The 1960s–1970s: evidence for multiple imino acid
transporters in the small intestine and kidney
3.1. The imino acid carrier in the rat small intestine
While the studies in the 1950s were focused on
identifying which neutral amino acids were substrates for
carrier-mediated absorption, studies in the 1960s provided
evidence for multiple carriers [36,37]. The first clear
evidence for the existence of more than one neutral aminoTable 1
Chronological summary of the names used to describe the imino acid carrier (SLC3
SLC36A1
1960s glycine–proline carrier Newey and Smyth [37]
imino acid carrier Munck [42]
“imino acid carrier” of the
small intestine of the rat
Munck [42]
system 4 Wiseman [1]
sarcosine system De la Noüe et al. [38]
sarcosine carrier Daniels et al. [40]
1970s methionine-insensitive
‘sarcosine–glycine–proline’
system
Thompson et al. [43]
β Miller et al. [58]
imino acid transport system Lerner and Karcher [59]
1980s N-methylamino acid or
sarcosine carrier
Munck [62]
H+-L-proline cotransport Røigaard-Petersen et al. [95]
H+ glycine co-transport system Rajendran et al. [94]
1990s proline–glycine–betaine pathway Wunz and Wright [103]
system 5 Wunz and Wright [103]
(using Mircheff et al.
nomenclature [105])
proton/amino acid transport,
proton/amino acid symport,
system PAT
Thwaites et al. [46,109]
rat imino acid carrier, rat IMINO Munck and Munck [80]
2000s LYAAT-1 Sagné et al. [140]
PAT1 Boll et al. [22] Chen et al. [23]
Tramdorin 3 Bermingham et al. [178]
Transporter names and references given in italics in this table correspond to observaacid transporter in rat small intestine came from a study by
Newey and Smyth [37]. Transepithelial transfer (and tissue
accumulation) of amino acids across rat small intestine were
determined in vitro and observations confirmed in vivo [37].
Evidence for two neutral amino acid carriers was produced.
The first had a high affinity for methionine and a much
lower affinity for glycine and proline. The second carrier
transported glycine and proline but had no affinity for
methionine or leucine. They named the second transporter
the glycine–proline carrier [37] but subsequently changed
the name to sarcosine system [38,39] or sarcosine carrier
[40,41] (Table 1). Two other groups also characterised this
transporter using everted sacs of rat small intestine in vitro
and they used the terms imino acid carrier [42] and
methionine-insensitive sarcosine–glycine–proline system [43]
(Table 1). This transport system corresponds to system 4 in
Wiseman's five-system classification for intestinal amino acid
transporters [1]. We shall use the term imino acid carrier
[42] to describe the characteristics of this transport system in6A1) and the IMINO transporter (SLC6A20)
SLC6A20
betaine carrier Lin et al. [36]
Hagihara et al. [49]
transport system for N-substituted amino acids Hagihara et al. [49]
“imino acid carrier” of the small intestine of
the hamster
Munck, [42]
system 3 Wiseman, [1]
PRO/MeAIB pathway Stevens et al. [64]
IMINO Stevens et al. [65]
IMINO transporter Stevens and Wright [66]
proline/sodium (IMINO) cotransporter Stevens and Wright [177]
Imino carrier Stevens and Wright [67]
system 5 Munck [69]
Imino, imino system, imino acid transport
pathway (IMINO system)
Satoh et al. [77]
imino pathway Wunz and Wright [103]
system 6 Wunz and Wright [103]
(using Mircheff et al.
nomenclature [105])
rabbit jejunal ‘imino carrier’,
rabbit ileal ‘imino acid carrier’
Munck and Munck [72]
rabbit imino acid carrier, guinea pig imino acid
carrier, rabbit IMINO, guinea pig IMINO
Munck and Munck [80]
SIT1 Takanaga et al. [152]
XT3s1 Kowalczuk et al. [153]
tions made using renal tissues.
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identified that rat small intestine possessed a transport system
for glycine, L- and D-alanine, β-alanine, L- and D-proline, L-
and D-hydroxyproline, sarcosine, betaine, β-aminobutyric
acid (β-ABA), γ-aminobutyric acid (GABA), L- and D-
azetidine-2-carboxylate, L- and D-pipecolic acid, with weaker
evidence for D-serine and α-aminoisobutyric acid (AIB) [37–
44]. It should be noted that these are all substrates for PAT1
(SLC36A1) [22,23,26,45–47] (see Table 2).Table 2
Tissue distribution and functional characteristics of the imino acid carrier
(SLC36A1)
Tissue distribution
mRNA Mammalian: small intestine (duodenum,
jejunum, ileum), oesophagus, stomach, caecum,
colon, rectum, kidney, placenta, liver, pancreas,
lung, heart, brain (neurones but not glial cells),
skeletal muscle, testes, spleen
[22,23,25,26,57,140,141,146]
Protein Brush-border membrane of the small intestine
(human, rat, Caco-2 cells); in neurones
primarily lysosomal but also plasma-membrane
and other sub-cellular organelles (rat)
[23,26,140,146,179]
Function Brush-border membrane of human Caco-2 cell
monolayers, human duodenal biopsies, rat small
intestinal mucosal sheets, rat small intestinal
BBMV, chicken small intestine, eel intestinal
enterocytes, brush-border of lizard small intestine,
rabbit renal (pars convoluta) BBMV,
plasma-membrane of dissociated rat
hippocampal neurones
[26,46,57–59,93–103,107–116,128–130,141,169]
Functional characteristics
Ion coupling H+-coupled (stoichiometry 1:1 H+:amino acid)
[22,109]
In intact intestinal epithelia is partially
Na+-dependent due to functional coupling with the
Na+/H+ exchanger NHE3 [26,46,56,109–111,114]
Electrogenicity Electrogenic transport of amino and imino
acids [22,26,45,46,107–111,114,116,143]
Electroneutral transport of short-chain fatty
acids [143]
General substrate
characteristics
Small unbranched, apolar, zwitterionic, α-, β-,
γ-amino and imino acids; D- and L-amino and
imino acids; heterocyclic amino and imino acids
containing 4- to 6-membered rings; N-methylated
amino and imino acids
Substrates glycine, D- and L-alanine, D- and L-proline,
D-serine, D-cysteine, D- and L-cycloserine,
trans-4-hydroxy-L-proline, β-alanine, taurine,
MeAIB, AIB, N-methyl-alanine,
sarcosine, dimethylglycine, betaine, GABA,
β-ABA, isonipecotic acid, nipecotic acid, D- and
L-pipecolic acid, D- and L-azetidine-2-carboxylic
acid, APSA, ACPC, AHA, TACA, vigabatrin,
guvacine, CHLP, cis-4-hydroxy-D-proline (CHDP),
3,4-dehydroproline, thiaproline, acetate,
propionate, butyrate, pentanoate, hexanoate
[23,24,26,37–43,46,47,61,62,81,107–116,143]
Non-transported inhibitors serotonin, L-tryptophan, 5-hydroxy-L-tryptophan,
tryptamine [144]Thompson et al. [43] found that decreasing bulk luminal pH
from pH 7.3 to pH 6.3 increased uptake of glycine, L-proline,
sarcosine and β-alanine in both phosphate and bicarbonate
buffered salines (whereas L-methionine uptake was unaffected)
which suggested that a pH-dependent transporter was present at
the mucosal surface of the rat small intestine. The idea that a
physiological pH gradient exists across the luminal surface of
the mammalian small intestine is supported by experiments
using ion-selective microelectrodes to demonstrate the “acid
microclimate” (an area of low pH adjacent to the mucosal
surface). In rat jejunum in vitro this microclimate has been
measured between approximately pH 6.1–6.8 [20,21]. Clearly
any manoeuvre which increases the H+ concentration at the
mucosal surface will likely stimulate transport via a pH-
dependent mechanism. Inclusion of glucose in the incubation
buffers bathing the mucosal surface of rat small intestine in vitro
causes a decrease in the surface pH [48] although the
mechanism responsible for this acidification is unclear. It is
interesting to note that in the studies of the imino acid carrier
discussed here, when glucose was included in the buffers
bathing the mucosal surface of the everted sacs of rat small
intestine in vitro there was an increase in uptake of glycine, L-
proline, β-alanine, sarcosine, D- and L-alanine (all PAT1
substrates) whereas L-methionine (which is excluded from
PAT1) uptake was unaffected [38,41,44]. Thus, by 1970, it was
apparent that there existed a transporter of both L- and D-amino
and imino acids that was driven by decreasing extracellular pH.
None of these studies investigated the Na+-dependence of
amino/imino acid uptake. It should be noted that PAT1
(SLC36A1) is a pH-dependent transporter of both L- and D-
amino and imino acids [22,23,26].
3.2. The betaine carrier in the hamster small intestine
At the same time that the imino acid carrier was being
characterised in rat small intestine (see Section 3.1 above)
similar studies were identifying the characteristics of amino and
imino acid transport across the small intestine of the hamster
[36,49,50]. As observed using rat small intestine, neutral amino
and imino acid uptake across the hamster small intestine was via
more than one transporter. A Na+-dependent transporter was
identified and named as the betaine carrier [36,49] or transport
system for N-substituted amino acids [49] (see Table 1). This
transporter has some similarities in substrate specificity to the
rat imino acid carrier as it accepts betaine, dimethylglycine,
sarcosine, proline, hydroxyproline and pipecolic acid but,
crucially, it excludes the imino acid carrier substrate glycine
[36,49,50]. The possibility that these differences in substrate
specificity of the rat imino acid carrier [37,42] and the hamster
betaine carrier [36,49] could be due to species differences was
raised by both Newey and Smyth [37] and Munck [42] in the
mid-1960s. Overall it is apparent that no evidence was produced
from these studies in hamster small intestine to support the role
of a transport system with identity to the rat imino acid carrier.
Indeed Wiseman [1] identified the two transporters as being
distinct with the betaine carrier corresponding to system 3 (as
stated above the imino acid carrier corresponds to system 4) in
184 D.T. Thwaites, C.M.H. Anderson / Biochimica et Biophysica Acta 1768 (2007) 179–197his five-system classification for intestinal amino acid trans-
porters [1] (see Table 1). Unfortunately this distinction, and the
possibility that there may be species-specific variation in the
complement of amino acid transport systems expressed at the
intestinal brush-border membrane, was seemingly forgotten for
much of the following 30–40 years.
3.3. The imino acid carrier in the kidney
Munck [42] observed the similarities between the rat
intestinal imino acid carrier and a transporter of proline,
hydroxyproline and glycine identified in the renal tubular
epithelium during investigation of hyperaminoacidurias
[51,52]. In some patients with familial hyperprolinemia
(characterised by renal loss of glycine, proline and hydroxypro-
line), prolinuria was observed only when the plasma proline
concentration was greater than 0.8 mM (normal levels are less
than 0.3 mM) [52]. However, when plasma proline was greater
than 0.8 mM there was also an increase in excretion of
hydroxyproline and glycine (despite plasma levels of both
remaining normal) suggesting the existence of a low-affinity
transport system shared by proline, glycine and hydroxyproline
[52] (indicative of transport via an imino acid carrier). At lower
plasma concentrations, the imino acids and glycine were
reabsorbed by separate high-affinity transport systems [52],
one of which could be the betaine carrier. A genetic defect in a
shared low-affinity transport system seems likely to be
responsible for the autosomal recessive disorder iminoglyci-
nuria (Online Mendelian Inheritance in Man (OMIM) database,
OMIM 242600, at www.ncbi.nlm.nih.gov) [51,53,54].
Mohyuddin and Scriver [55] characterised imino acid and
glycine transport in rat kidney and identified a series of
transport systems with characteristics that could account for the
reabsorptive processes identified in man [52,53]. These
included separate high affinity [Michaelis constant (Km),
0.1 mM] transport systems for glycine and proline, and a low
affinity transport system (glycine Km, 2.7 mM; proline Km,
5 mM) which was shared by the imino acid carrier (and PAT1)
substrates proline, hydroxyproline, glycine, alanine and AIB
[55]. Interestingly, unlike many neutral amino acid transporters,
the low-affinity (imino acid carrier-like) transport system did
not show absolute dependence on extracellular Na+ as proline
accumulation in rat kidney cortex slices was reduced by only
31% (at a proline concentration of 3 mM) following
extracellular Na+ removal [55]. The characteristic of partial
Na+-dependence in intact epithelial preparations [26,56,57] is
consistent with PAT1 (SLC36A1) function at the brush-border
of the proximal tubule.
3.4. Conclusions from studies during the 1960s–1970s
By the early 1970s, evidence from studies in human and rat
intestinal and renal tissues suggested the existence of a low
affinity transport system for imino and amino acids (the imino
acid carrier) that: (i) showed weak stereospecificity; (ii) was
pH-dependent, being stimulated by low pH; and (iii) was only
partially Na+-dependent. These are all characteristics that arenow associated with the function of PAT1 (SLC36A1) in intact
epithelial tissues [26,56,57]. Evidence from studies using
hamster small intestine failed to provide any evidence for an
imino acid carrier-like transport system but instead demon-
strated the presence of a transporter (the betaine carrier) with a
distinct substrate selectivity.
4. The 1970s–1990s: species differences in intestinal imino
(amino) acid transport
4.1. The imino acid carrier in rat and chicken small intestine
Multiple amino and imino acid transporters have been
identified in chicken small intestine [58]. Although there are
some inconsistencies in the studies, one of these transporters,
named as β or as an imino acid transport system [58,59], (Table
1) can be identified as a low affinity (Ki 3–8 mM for proline, β-
alanine and GABA) carrier of proline, β-alanine, GABA, D- and
L-imino acids, taurine, sarcosine, AIB, D- and L-alanine, and L-
azetidine-2-carboxylic acid [58–60]. Over the substrate range
investigated this selectivity is identical to observations of
mucosal influx via the imino acid carrier in rat small intestine
[61,62]. In addition to those substrates identified in the chicken,
in the rat small intestine the heterocyclic piperidine carboxylic
acids pipecolic, nipecotic and isonipecotic acid were identified
as substrates for this carrier along with D-serine and D-alanine
[61,62]. When reviewing the literature in 1981, Munck [62]
concluded that amino acid uptake across the intestinal brush-
border membrane was via four carriers, one of which
transported imino acids and amino acids containing the amino
group in the β- or γ-positions. He described this carrier as the
imino acid carrier or N-methylamino acid or sarcosine carrier
(Table 1) although suggested that alternative names might be
more appropriate once the range of transported substrates had
been identified. We could append here that the transporter name
might need revisiting once the mechanism of ion-coupling is
identified. The observation of D-alanine transport via the imino
acid carrier is interesting as even in the original demonstration
of Na+/L-alanine cotransport using rat intestinal BBMV it was
also observed that D-alanine uptake, although not being Na+-
dependent (as demonstrated by the absence of a Na+-dependent
overshoot), was carrier-mediated and reduced in the presence of
glycine [14], characteristics consistent with PAT1 (SLC36A1)
function even in the absence of a pH gradient.
4.2. The Na+-dependent IMINO transporter in rabbit and
guinea pig small intestine
From the late 1960s onwards, the rabbit became a popular
choice for investigations of intestinal amino acid uptake either
via influx into intact mucosal sheets or BBMV [12,13,63–73].
Few early studies investigated uptake of imino acids although a
small component (5%) of mucosal uptake of glycine was
inhibited by proline suggesting low level expression of a shared
transporter in rabbit ileum [63]. In the 1980s, imino acid uptake
was investigated intensively using rabbit jejunal BBMV in a
series of studies by Stevens, Wright and colleagues [64–67].
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transporters for neutral amino acids and named one of these
transporters sequentially the Pro/MeAIB Pathway [64], IMINO
transporter [65,66] or Imino carrier [67] (Table 1). This
transporter has been generally called the IMINO transporter
over recent years and we will use that name in this review.
Although the IMINO transporter has some similarities with the
imino acid carrier described earlier in rat small intestine there
are clear differences in both substrate selectivity and ion
dependency (see below and Section 4.3). The rabbit IMINO
transporter has a higher affinity for proline than the rat imino
acid carrier with a Km of approximately 200–300 μM [66,67].
Like the rat imino acid carrier, the rabbit IMINO transporter
accepts heterocyclic compounds (e.g. proline and pipecolic
acid) and N-substituted amino acids [e.g. sarcosine, betaine,
α(methyl)aminoisobutyric acid (MeAIB)] but is stereoselective
(with a preference for L- over D-enantiomers), and excludes a
number of substrates for the rat imino acid carrier including β-
alanine, GABA, glycine, L-alanine, AIB and taurine [66,69,73].
The jejunal BBMVused in those studies [64–67] were prepared
using a Ca2+-precipitation technique which produced a BBMV
population devoid of any β-alanine transport [74]. However, the
method of preparation does not appear to effect the functioning
of the IMINO transporter (nor is it the reason for the lack of
effect of β-alanine on the IMINO transporter) in those studies as
a similar substrate specificity was identified when uptake was
measured by influx across intact mucosal sheets of rabbit ileum
[69]. Influx via the IMINO transporter is equivalent to the 5th
system of the five transporters identified at the rabbit ileal
brush-border membrane by Munck [69].
Similar observations to those described in rabbit small
intestine were made in guinea pig small intestine using either
BBMV or intact mucosal sheets [75–77]. The IMINO
transporter in the guinea pig was initially incorrectly attributed
to a system A-like transporter (due mainly to the incorrect, but
very common, assumption that MeAIB is a specific system A
substrate) [75]. It should be noted that system A is found
exclusively at the basolateral membrane of intestinal enter-
ocytes [64,65,78]. The substrate selectivity of this guinea pig
IMINO transporter is identical to the rabbit IMINO transporter
and the hamster betaine carrier (see section above) suggesting
that the IMINO transporter and the earlier-identified betaine
carrier represent functional activity of the same transport
system (Table 1). The IMINO carrier is defined as the Na+-
dependent component of proline uptake that is insensitive to L-
alanine [66,67].
4.3. Comparative studies of the imino (amino) acid
transporters in rat, rabbit and guinea pig small intestine
The summary of the experimental evidence given above
suggests that the transporters of imino and amino acids at the
brush-border membranes of different species are distinct with an
imino acid carrier-like transporter being expressed predomi-
nantly in rat and chicken and an IMINO-like transporter being
primarily responsible for uptake in rabbit, guinea pig and
hamster small intestine [36–43,49,50,58–62,64–69,75–77].These differences in both substrate selectivity and ion depen-
dency were the focus of a number of studies by Munck and
colleagues in the early 1990s [71–73,79–81]. A key difference
in substrate specificity between species is that in the rat (imino
acid carrier) there is either no discrimination between L- and D-
forms of amino acids (e.g. proline, hydroxyproline) or a
preference for the D-form as is the case with serine and alanine
[38–41,61,62,68,81]. In contrast the rabbit and guinea pig
IMINO transporter prefers proline and hydroxyproline in the L-
form [66,68,69,76]. Two groups of substrates in particular
display the key differences in the selectivity of the imino acid
carrier and IMINO transporters (Fig. 1). The rat imino acid
carrier has a clear preference for aminobutyric acid when the
amino group is in the β-(β-ABA) or γ-(GABA) position and
has little affinity when the amino group is in the α-(α-ABA)
position (Fig. 1) [39,61,62,68,80,81]. In the rabbit and guinea
pig this preference is reversed [66,68,69,76]. These differences
are emphasised by the fact that the β amino acids β-alanine and
taurine are substrates for the rat imino acid carrier but are
excluded by the rabbit and guinea pig IMINO transporters
[38,39,41,61,62,66,68,73,76,80,81]. The second group of
compounds that distinguish the transport sites of these carriers
are the heterocyclic piperidine carboxylates where there is a
relatively poor discrimination by the rat imino acid carrier but a
slight preference when the amino group is in the γ-(isonipecotic
acid) or β-(nipecotic acid) positions compared to the α-
(pipecolic acid) position (Fig. 1) [61,62,68]. In contrast, the
rabbit and guinea pig IMINO transporter has a clear preference
for pipecolic over nipecotic over isonipecotic acid (Fig. 1)
[66,68,69,76].
The ion dependency of the rat imino acid carrier and rabbit
and guinea pig IMINO transporter are also distinct. Studies
using BBMV demonstrate unequivocally that the IMINO
transporter is Na+-dependent in both rabbit jejunum [64,67]
and guinea pig ileum [75,77]. In contrast, it is surprising that
there are no published studies of Na+-dependent imino acid
carrier- (or even IMINO-) like transport of, for example, proline
or MeAIB in studies using rat intestinal BBMV. When the Na+-
dependency of these transporters was investigated by rapid
influx using mucosal sheets it was clear that MeAIB uptake was
completely Na+-dependent in rabbit ileum and guinea pig
jejunum but was only partially Na+-dependent (approximately
40% of uptake was detected even in the absence of Na+) in rat
jejunum [71,79], as observed previously in rat renal cortex [55].
In addition, IMINO transport activity in the rabbit ileum and
guinea pig jejunum was Cl−-dependent whereas imino acid
carrier function in the rat jejunum was Cl−-independent
[71,79,82]. The rat imino acid carrier is pH-dependent [43].
We can find no information about the pH dependence of the
IMINO transporter from studies using BBMVor intact tissues.
4.4. Conclusions from intestinal studies during the
1970s–1990s
With the benefit of hindsight it seems clear that there are at
least two major intestinal transporters of imino (and amino)
acids namely the imino acid carrier [37,42,61,62] and the
Fig. 1. Schematic representation of the order of preference of the imino acid carrier (SLC36A1) and the IMINO transporter (SLC6A20) for two groups of compounds
where the amino (or imino) group is in the α-, β- or γ-position.
186 D.T. Thwaites, C.M.H. Anderson / Biochimica et Biophysica Acta 1768 (2007) 179–197IMINO transporter (betaine carrier) [36,65,66,69] (Table 1).
There are some similarities between these two carriers notably
in substrate selectivity but also clear differences both in
substrate selectivity and ion coupling [61,62,65,66,68,69,79–
81]. The relative levels of expression of these two carriers at the
intestinal luminal surface appear to vary between species and
may vary along the length of the small intestine. However, from
the 1980s onwards most reviews and papers of amino and imino
acid transport (with the notable exception of those by Munck
and Munck) include evidence for, or discussion of, the IMINO
transporter but not the imino acid carrier. There is probably no
single reason for this but a few possibilities are suggested here.
Firstly, as described above and raised by some investigators
of intestinal amino acid transport, species differences in terms of
amino acid transport do occur but are often ignored. This
omission has been exacerbated by the increased use of the rabbit
as the main model of investigation from the 1960s onwards.
Obviously any transport system not expressed, to any great
degree, in the rabbit small intestine will cease to be the focus of
much research activity or the centre of attention when discussed
in review (no matter how well characterised that transporter
may have been, and important it may have been considered, in
the 1960s and 1970s) [1,37–43,61]. This is emphasised as the
classification system used to name and identify intestinal amino
acid transporters from the 1980s to the present day is primarily
influenced by studies using rabbit small intestine [65,70,80,84–
87]. Apart from Munck and colleagues [68,80] few reviewsdescribe the results of studies using rat tissue (and the imino
acid carrier) or those aimed at identifying species differences.
Secondly, and this point is closely related to the first, it is
probably true that most people (again with some exceptions
[79–81,83]) who were aware of the existence of studies of both
the imino acid carrier and IMINO transporter may have
considered that these two transport systems simply represented
species-specific congeners of the same carrier, even though the
two transport systems were recognised as long ago as the 1960s
as being two separate entities [1].
Thirdly, much of the work on intestinal amino and imino acid
transport from the 1980s onwards has used BBMV (prepared
predominantly from rabbit small intestine) as the main
experimental tool. The introduction of rapid measurements of
amino acid influx across the mucosal surface had earlier
allowed identification of the substrate specificity and ion-
coupling of the amino acid transporters at the brush-border
membrane of the rabbit small intestine. These observations were
confirmed and expanded greatly by the use of rabbit intestinal
BBMV in the 1980s [64–67]. In the rat small intestine, evidence
for the imino acid carrier provided from studies in the 1960s,
using, for example, everted sacs, was supported by the rapid
mucosal influx measurements made during the 1970s–1990s
[61,62,68,81]. However, these observations may have been
ignored subsequently because they could not be confirmed
using rat intestinal BBMV. The reason for this apparent lack of
consistency could be that investigators were attempting to
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coupled dogma or perhaps an assumption that the rat imino acid
carrier should have a similar ionic-coupling to the rabbit
IMINO transporter (see Section 4.3). In hindsight there is no real
evidence to suggest that the imino acid carrier is truly Na+-
coupled.
Fourthly, the confusion regarding the names given to
these two transport systems is enough to bewilder even the
most discerning reader (Table 1). Even Munck and Munck,
who were the most persistent investigators involved in
characterising these different transporters and highlighting
differences in function, used both ‘imino carrier’ and ‘imino
acid carrier’ terms to describe the rabbit IMINO transporter
when comparing amino acid uptake in rabbit jejunum and
ileum [72]. Similarly both IMINO transporter and imino
acid carrier terms were used to describe both transporters in
their review in 1994 [80]. However, the chaotic nomen-
clature is demonstrated most “clearly” by the fact that,
within the same UK Physiology Department over a period
of 3 years, three separate research groups published articles
on the same rat imino acid carrier but gave it a multitude
of different names (Table 1) [1,38–40,43]. If departmental
colleagues could not agree on a single name it is not
surprising that the rest of the scientific community became
confused!
Thus, the result of these studies in the 1970s–1990s is
that, despite extensive evidence for two separate amino and
imino acid transporters, only the IMINO transporter name
has remained in the literature and generally the studies cited
are those that describe observations made using rabbit small
intestine. This focus is emphasised if we consider published
reviews over this time-frame. Since 1984 there have been a
number of excellent reviews on amino and imino acid
transport some of which have been focused on intestinal
mechanisms while others have included sections on, or at
least discussion of, the transporters expressed in the small
intestine [65,84–90]. This list is by no means exhaustive but
does point to the reason why the imino acid carrier name
and data have disappeared from the consciousness of the
current research community. A Web of Knowledge search
[91] as of June 2006, demonstrates that these reviews
[65,84–88,90] are influential, widely-read and quoted,
attracting 1339 citations between them. Notably these
reviews all identify the IMINO transporter and associated
studies but none include any reference to the imino acid
carrier and the studies in rat small intestine. In contrast, the
most recent reviews (1994–1995) [80,92] to describe the
imino acid carrier and underline the species differences
between rabbit, guinea pig and rat have attracted only 53
citations. Earlier reviews (1968–1983) [1,61,62,68] that
included details of the imino acid carrier have been cited
267 times in total but very infrequently over the last
20 years. Similarly, if we look at the original data for the
two transporters, although the original studies of the imino
acid carrier by Newey and Smyth [37], and Munck [42]
attracted 158 citations, later studies [39–41,43,79,81]
average only 21 citations per paper. In contrast, the originalIMINO (and betaine carrier) papers by Lin et al. [36] and
Stevens et al. [64] have attracted 444 citations whereas the
later studies [66,67,69] average 60 citations per paper. Thus,
it is clear, that we, the scientific community have concluded
erroneously that the IMINO transporter and imino acid
carrier are one and the same and subsequently ignored most
comparative studies. Thus, most people in the field are
aware of the IMINO transporter but few are aware of the
functional characteristics (substrate specificity and ion
coupling) of the imino acid carrier. The question is then:
is there any recent evidence in the literature for an imino
acid carrier-like transporter and what role might it play?
5. The 1980s–1990s: the pH-dependent, Na+-independent,
amino and imino acid transporter in rabbit renal
brush-border membrane vesicles
Studies using BBMV prepared from the rabbit renal pars
convoluta identified a low affinity transport system which had
several characteristics (substrate affinity, substrate specificity
and pH dependence) similar to those described for the imino
acid carrier in rat small intestine [93–103]. However, the link
between the imino acid carrier and the pH-dependent, Na+-
independent, renal transporter was not made and although
many of these intestinal and renal studies were published over
a similar time-frame it is important to appreciate that there
was no cross-referencing between these studies of intestinal
and renal imino and amino acid transport [37–43,61,62,
68,69,76,79–81,93–103]. In the rabbit renal BBMV, transport
of D- and L-imino and amino acids was rheogenic (even in
the absence of Na+), was increased by lowering extravesi-
cular pH and was pH gradient-dependent (reduced in the
presence of the H+ ionophore FCCP). These data suggested
that transport occurred via a H+/amino acid symport
mechanism [93–103]. A Na+-independent, pH-dependent,
rheogenic uptake of proline, hydroxyproline, glycine, β-
alanine, L-alanine, taurine, betaine and AIB (all imino acid
carrier and PAT1 substrates) was detected [93–103] and the
relative low affinity (Km, 2.8–9.7 mM) was similar to that
determined either using rat kidney slices in vitro or in vivo in
humans [52,55]. Cross-competition experiments demonstrated
that this low affinity transport system accepts sarcosine,
and L- and D-forms of alanine, proline and hydroxyproline
[94,96,98,99].
In addition to the pH-dependent, Na+-independent, imino
acid carrier-like transporter described above a Na+-dependent,
high-affinity (Km 160–260 μM for proline and hydroxyproline),
IMINO-like transporter was identified in BBMV prepared from
rabbit renal pars recta or total cortex which also transported D-
imino acids and betaine [93,96,103,104]. This IMINO function
probably corresponds to system 6, of the six Na+-dependent
amino acid transport systems identified earlier by Wright and
colleagues, suggested as being defective in prolinuria
[103,105]. Recently, Miyauchi et al. [57] demonstrated
functions consistent with expression of both imino acid carrier
and IMINO-like transporters in BBMV prepared from rabbit
kidney.
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6.1. H+-coupled, pH-dependent, Na+-independent amino and
imino acid transport
In 1994, Munck and colleagues [81] considered the species
differences described above and posed the following question:
“… it becomes a question of more general and clinical interest of
which species, guinea pig, rabbit, or rat, is the best model for the
function of the human small intestine”. Clearly the best model
of the human small intestine is the human small intestine.
However, mechanistic investigation of membrane transport
across the human small intestine is difficult due to the lack of
available viable human tissue samples. The Caco-2 cell line has
been used extensively over the last 15 years as a model system
for transport studies across the human small intestinal
epithelium. This model system has a number of key advantages
as the cells are of human origin, allow easy access to both the
apical and basolateral surfaces of the enterocyte, express a small
intestinal phenotype and consequently provide a useful model
for transcellular measurements [106]. These advantages must be
considered alongside the fact that the cells originate from a
colonic cancer and this colonic origin influences the high
resistance nature of the epithelium and paracellular pathway
[106]. Despite these potential limitations, Caco-2 cell mono-
layers grown on permeable filters probably represent the best
available model for studies of transcellular movement across the
human small intestinal epithelium.
Thwaites and colleagues used confluent monolayers of the
human intestinal epithelial cell line Caco-2, grown on permeable
filters, to demonstrate that the brush-border membrane of
intestinal cells possessed a H+-coupled, pH-dependent, rheo-
genic imino and amino acid transport system which functioned
even in the absence of extracellular Na+ [46,107–114]. This
transport system was named system PAT [46,109] (Table 1).
Direct evidence for H+/amino and imino acid symport was
produced using Caco-2 cell monolayers loaded with the pH-
sensitive dye 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein
(BCECF) [107,108]. Transport of these zwitterionic substrates
was shown to be rheogenic, even in the absence of extracellular
Na+, by inward short-circuit current (Isc) measurements in Caco-
2 cell monolayers under voltage-clamped conditions [107,108].
This series of studies demonstrated pH-dependent uptake of the
imino acid carrier substrates β-alanine, L-proline, L-alanine,
MeAIB, glycine, AIB, taurine, GABA and betaine [45,46,107–
112,114]. In contrast, uptake of amino acids excluded from the
imino acid carrier such as leucine [111], phenylalanine [46],
glutamic acid [112] and lysine [112] was not stimulated
following a decrease in apical pH. A combination of cross-
competition experiments, measurements of amino acid-stimu-
lated decrease in intracellular pH, and measurements of amino
acid-induced inward Isc in Na
+-free conditions demonstrated
that this human system PAT, like the rat imino acid carrier,
mediated transport of D- and L-proline, D- and L-alanine, D-
serine, D-cycloserine, trans-4-hydroxy-L-proline, β-alanine,
taurine, glycine, MeAIB, AIB, sarcosine, dimethylglycine,betaine, GABA, β-ABA, isonipecotic acid, nipecotic acid, D-
and L-pipecolic acid, and L-azetidine-2-carboxylic acid (Table 2)
[23,24,26,27,46,107–115]. In addition, system PAT also trans-
ported D-cysteine [23], L-cycloserine [26], and a number of
amino and imino acid analogues including 3-amino-1-propane-
sulfonic acid (APSA or homotaurine) [114], 1-aminocyclopro-
panecarboxylic acid (ACPC) [114], 4-amino-5-hexynoic acid
(AHA or γ-acetylenic GABA) [116], trans-4-aminocrotonic
acid (TACA) [116], vigabatrin (or 4-amino-5-hexanoic acid or
γ-vinyl GABA) [116], guvacine [116], cis-4-hydroxy-L-proline
(CHLP) and 3,4-dehydroproline [47] (Table 2). Despite the
extensive evidence for the role of this transport system in
intestinal absorption of amino and imino acids, orally-delivered
amino acid analogues used clinically to treat various neurolo-
gical disorders, antibiotics, and a variety of GABA (receptor
blockers and reuptake inhibitors) and proline analogues
(including those which reduce collagen deposition in fibrotic
diseases and inhibit cancer growth in vitro) [47,115–125],
evidence for system PAT is not included in most reviews of
amino acid transport. The lack of impact that these studies made
on the scientific literature is probably due to the fact that the
transport activity was considered by some to be an artefact of the
Caco-2 cell line. This view was understandable because, firstly,
there was apparently no evidence for a H+-coupled amino or
imino acid transporter in real intestinal tissues (this conclusion
was incorrect, see Sections 6.2 and 7.1). Secondly, and
unfortunately, the publication of the system PAT Caco-2 studies
was coincident with the disappearance of discussion of the imino
acid carrier from the literature so that there was apparently no
evidence for a transporter with similar substrate selectivity to
system PAT. The existence of this H+-coupled amino and imino
acid carrier was acknowledged in some reviews in the 1990s
[92,126,127] and similarities with other transport systems
discussed [92,127]. However, the apparent differences in ion-
dependency between system PAT and ‘classical’ Na+-dependent
transport systems prevented confirmation of any functional
equivalence [46,92,111,114,127].
6.2. The partial Na+-dependence of system PAT in intact
epithelia and the role played by the Na+/H+ exchanger NHE3
Overall, it is clear, that the similarity in substrate specificity
between the human system PAT and rat imino acid carrier
demonstrates that they represent functions of identical transport
systems at the brush-border of human and rat small intestine.
However, the major problem in attempting to unite the evidence
for the imino acid carrier and system PAT has been the
apparently incontrovertible difference in ion coupling with the
imino acid carrier being considered, like most ‘classical’
amino acid transporters, to be Na+-coupled whereas system
PAT, in Caco-2 cells, is clearly H+-coupled [26,46,56,107–
114,116]. There is considerable evidence for a pH-dependent
imino and amino acid transporter in the kidney (as described in
Section 5) [93–103] and small intestine (see below) which
appears identical in substrate selectivity to both system PAT and
the imino acid carrier. Thompson et al. [43] demonstrated that
the rat imino acid carrier was pH-dependent (although
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cellular Na+). In 2004, Anderson et al. [26] demonstrated that,
in Na+-free conditions, MeAIB uptake across the mucosal
surface of rat small intestine was pH-dependent and was
inhibited by β-alanine, observations consistent with expression
of a Na+-independent, pH-dependent, H+-coupled system PAT/
imino acid carrier-like transporter. In contrast, no Na+-
independent pH-dependent MeAIB uptake was measured in
rabbit or guinea pig small intestine [26]. Recently pH-dependent
(Na+-independent) uptake of L-proline and β-alanine was
demonstrated in rat intestinal BBMV [128]. In addition, H+-
coupled L-proline transport has been demonstrated in eel
(Anguilla anguilla) intestinal enterocytes (localised solely to
the apical membrane) [129] and Na+-independent, pH-depen-
dent, transmural L-alanine transport (mucosal-to-serosal) has
been demonstrated across lizard (Gallotia galloti) duodenal
enterocytes [130].
There is in fact no evidence to suggest that the imino acid
carrier is truly Na+-coupled, only the Na+-coupled dogma and
the incorrect assumption that the Na+-coupled IMINO trans-
porter represents the same carrier. Munck and Munck [79]
demonstrated that the imino acid carrier in rat jejunum was
only partially Na+-dependent and could function even in the
absence of Na+. A series of key experiments have led us to a
model (Fig. 2) that identifies why the imino acid carrier is
partially Na+-dependent in intact epithelia whilst functioning as
a H+-coupled transport system. For optimal activity of the
system PAT/imino acid carrier to occur it is essential that the
transapical membrane pH gradient is maintained. Amino acid-
induced intracellular acidification in Caco-2 cell monolayers
(due to system PAT-mediated H+/amino acid influx) leads to a
selective activation of an apical Na+-dependent H+-efflux
mechanism (Na+/H+ exchanger) without any activation of the
housekeeping basolateral Na+/H+ exchanger NHE1 [26,46,56,
109–111,113,114]. This apically-localised Na+/H+ exchanger
was identified as NHE3 by use of selective Na+/H+ exchange
inhibitors [26,56,113,131–133]. Pharmacological inhibition
(e.g. by the NHE3-selective inhibitor S1611) or physiologicalFig. 2. Schematic representation of the ion-coupling of the imino acid carrier
(SLC36A1 and SLC9A3) and the IMINO transporter (SLC6A20) at the brush-
border membrane of the small intestinal epithelium.inhibition (e.g. by vasoactive intestinal peptide) of NHE3
reduces the absorptive capacity for system PAT-mediated amino
acid uptake across the apical membrane of Caco-2 cell
monolayers [26,56]. Similarly, system PAT function in Caco-2
cells shows partial Na+-dependence, following inactivation of
NHE3 (due to the absence of Na+) [26,56], as observed
previously for the imino acid carrier [79]. This functional
cooperativity has also been demonstrated for NHE3 and another
H+-coupled solute transporter, the intestinal di/tripeptide
transporter hPepT1 [134–139]. Thus, during H+-coupled solute
absorption the driving force (the H+ electrochemical gradient) is
maintained by activity of the Na+/H+ exchanger NHE3 so that
the overall effect is net transport of solute and Na+ with H+
recycling (Fig. 2). Final confirmation that the sum of system
PAT and NHE3 functions account for that attributed previously
to the imino acid carrier (as described in rat small intestine)
required that the system PAT-related cDNA clone was isolated
to allow definitive ion-coupling and substrate specificity to be
elucidated.
7. The 2000s: molecular identification
7.1. The imino acid carrier or system PAT
The significant breakthrough in molecular identification of
the imino acid carrier/system PAT came with the isolation of
a cDNA from rat brain which was named LYAAT-1
(Lysosomal Amino Acid Transporter 1) because of its colo-
calisation with the lysosomal marker cathepsin D in the
neurones investigated [140]. LYAAT-1 functioned in a similar
manner to system PAT as a Na+-independent pH-dependent
transporter of GABA, L-proline and L-alanine which was
inhibited by D-proline. Therefore, the primary physiological
function of LYAAT-1 in neurones may be to export neutral
amino acids from lysosomes into the cytosol using the
outward H+-electrochemical gradient generated by H+-ATPase
activity [140]. No reference to the extensive imino acid
carrier or system PAT literature was included and the con-
clusion made was that LYAAT-1 was a lysosomal specific
transporter [140]. LYAAT-1 has since been shown to function
at the plasma-membrane of hippocampal neurones in culture
[141]. Related cDNAs have been isolated from mouse [22],
human [23] and rabbit [57] and named PAT1 (Table 1) due to
the similarity in function between the isolated transporter
when expressed in mammalian cell lines or Xenopus laevis
oocytes and the system PAT transporter in Caco-2 cells. PAT1
functions as a rheogenic H+-coupled, pH-dependent, Na+-
independent transporter of D- and L-amino and imino acids
[22,23,26,45]. In PAT1-expressing oocytes, transport is
dependent upon membrane potential with hyperpolarisation
increasing both substrate affinity and maximal capacity [142].
It is predicted that proton binding precedes amino acid
substrate binding but that translocation is simultaneous [142].
Decreasing extracellular pH decreases the Km for substrate
binding [142]. In oocytes, PAT1 can function bidirectionally
with the direction of transport being governed by the relative
electrical and chemical gradients for protons and amino acid
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under physiological conditions (e.g. in the enterocyte) remains
unknown although the lower substrate affinity on the cyto-
solic face of the transporter favours influx [142]. The
substrate selectivity of PAT1 is identical to system PAT at
the apical membrane of Caco-2 cell monolayers (Table 2)
[22,23,26,45]. In addition, PAT1 transports short-chain fatty
acids (e.g. acetate and butyrate) in an electroneutral manner
[143] and serotonin and L-tryptophan appear to be natural
inhibitors of the carrier as they inhibit PAT1 function but are
not transported [144]. As observed with the imino acid
carrier in rat small intestine [39,61,62], and system PAT in
human Caco-2 cell monolayers [26], PAT1 has a clear
preference for aminobutyric acid when the amino group is in
the β-(β-ABA) or γ-(GABA) position and has little affinity
when the amino group is in the α-(α-ABA) position (Fig. 1).
Similarly, PAT1 (like system PAT and the imino acid carrier)
only poorly discriminates between the heterocyclic piperidine
carboxylates when the amino group is in the γ-(isonipecotic
acid) or β-(nipecotic acid) positions compared to the α-
(pipecolic acid) position (Fig. 1) [26].
At the mRNA level, PAT1 has a ubiquitous tissue dis-
tribution (Table 2) [22,23,26]. At the protein level, immuno-
cytochemistry using a PAT1-specific antibody localised PAT1
exclusively to the brush-border membrane of Caco-2 cell
monolayers and both human and rat small intestine (Table 2)
[23,26]. The identical expression pattern in Caco-2 cell
monolayers and real human small intestine confirm that the
Caco-2 cell line is an appropriate model for investigation of
imino and amino acid absorption [26]. The brush-border
localisation of PAT1-immunoreactivity in rat small intestine
[26] support the role for PAT1 in pH-dependent, Na+-
independent amino and imino acid uptake in rat small intestine
[26,128] and as a molecular candidate for the imino acid
carrier.
The NHE3 selective inhibitor S1611 inhibits the Na+-
dependent component of system PAT function in Caco-2 cells
but has no effect on amino acid uptake under conditions when
NHE3 is inactive (e.g. in the absence of extracellular Na+, at
apical pH 5.5, or under conditions in which NHE3 is inactivated
following an increase in [cAMP]i). This demonstrates that the
effect of S1611 on system PAT function is indirect following
inhibition of maintenance of the driving force (the H+-
electrochemical gradient) for further H+-coupled transport
[26,56]. S1611 has no effect on amino acid uptake into PAT1-
expressing oocytes demonstrating that selective NHE3 inhibi-
tors have no direct effect on PAT1 function [26]. These
observations confirm that in intact intestinal epithelial tissues
the transport system identified as the imino acid carrier is the
result of functional cooperativity [26] between the H+/amino
and imino acid symporter PAT1 and the Na+/H+ exchanger
NHE3 (Fig. 2). Apart from the studies in Caco-2 cells, the only
other series of studies to describe a H+-coupled system PAT/
imino acid carrier-like transporter were those that reported a
pH-dependent imino and amino acid transporter in rabbit renal
BBMV [93–103]. Rabbit PAT1, when expressed heterolo-
gously in human retinal pigment epithelial (HRPE) cellsfunctions in an identical mode and with identical substrate
specificity to the endogenous transporter characterised in renal
BBMV [57].
Interestingly, PAT1 is the first of 4 related sequences to be
identified and PAT1, therefore, is also known as SLC36A1,
the first member of solute carrier family 36 [24–26,145,146].
The human PAT1 gene SLC36A1 is localised to chromosome
5q33.1 and is clustered with SLC36A2 and SLC36A3 whereas
SLC36A4 is found on 11q14.3; similar clusters are observed in
all mammalian genomes identified so far [23–25,145,146].
PAT2 (SLC36A2) is also a H+-coupled, pH-dependent, Na+-
independent amino and imino acid transporter but has a more
restrictive substrate specificity than PAT1 and has a higher
affinity for its substrates [22,145,147,148]. PAT2 has a more
restricted tissue distribution than PAT1 and is not expressed in
the small intestine [22,25,145]. The physiological role of
PAT2 remains unknown. However, in neurones, PAT2 is
expressed in the endoplasmic reticulum, recycling endosomes
and the plasma-membrane [149] and PAT2 has been suggested
as a candidate [149] for the low affinity Na+-independent
glycine transporter identified functionally in rat cerebral cortex
slices and homogenates [150]. An interesting and additional
physiological role for PAT2 has recently been suggested by
Bröer [151] which reflects the ability of PAT2 (like PAT1) to
transport the three amino/imino acids (glycine, proline,
hydroxyproline) lost in urine in iminoglycinuria [151]. PAT2
mRNA has been detected in kidney [22,25, 145,146].
Although there does not appear to be any functional evidence
for PAT2 in renal amino acid transport, PAT2 function may
have been overlooked in BBMV studies (Section 5 above)
since transport is Na+-independent and PAT2 has a pH-
dependency (half-maximal transport activity at e.g. pH 8.3
[149]) that might preclude detection of function over the range
of extravesicular pH values used in the studies. Bröer
suggests, therefore, that iminoglycinuria is likely to be a
multigene disorder which involves several transporters
including PAT1, PAT2 and the IMINO transporter [151]. No
function has yet been identified for PAT3 (SLC36A3) and
PAT4 (SLC36A4).
7.2. The IMINO transporter
The IMINO transporter or betaine carrier has been
identified at the molecular level and corresponds to the
20th member of solute carrier family 6 or SLC6A20 [152,
153]. The transporter has been isolated from rat, human and
mouse and named either SIT1 (for Sodium/Imino-acid
Transporter 1) or XT3s1 [152,153]. The human SLC6A20
gene has a distinct chromosomal localisation to the SLC36A1
gene being found at 3p21. SIT1/XT3s1 functions as a Na+-
dependent and Cl−-dependent amino and imino acid trans-
porter with substrate specificity and affinity identical to the
earlier observations of the IMINO transporter and betaine
carrier using rabbit, guinea pig and hamster small intestine
[36,49,64–69,76]. The ion-coupling and substrate selectivity
of SIT1/XT3s1 are distinct to those observed with PAT1
(Fig. 2).
191D.T. Thwaites, C.M.H. Anderson / Biochimica et Biophysica Acta 1768 (2007) 179–1977.3. A third transporter: system B0
A third transporter may also play a role in amino and imino
acid absorption in the small intestine and kidney. When Newey
and Smyth [37] first described the imino acid carrier in rat
small intestine they also detected a separate transporter that had
a high affinity for methionine and a much lower affinity for
glycine and proline. This methionine carrier most probably
corresponds to the Na+/L-alanine symporter characterised in the
1960s–1980s in rabbit and rat small intestine [12–14,63–65].
This transporter has been named variously as the neutral amino
acid transport system [36,49], neutral amino acid carrier [49],
methionine system [38], methionine carrier [40], system 1
(usingWiseman's five-system classification for intestinal amino
acid transporters) [1], Common Neutral Amino Acid Pathway,
[64], system NBB (for Neutral Brush Border) [65], system B
[90], and is now known as system B0 [154]. System B0 has been
identified at the molecular level and corresponds to the 19th
member of solute carrier family 6 or SLC6A19 [155]. The
transporter has been isolated from mouse and named B0AT1
[155]. The system B0 transporter B0AT1 (SLC6A19), like the
IMINO transporter SIT1/XT3s1 (SLC6A20), has been immu-
nolocalised to the brush-border membrane of the mouse small
intestinal epithelium [156]. B0AT1 prefers large aliphatic amino
acids such as leucine and methionine with methionine inducing
the largest inward current in B0AT1-expressing oocytes
[155,157]. Glycine, L-alanine and proline are accepted but
with much lower affinity [155,157] suggesting that the system
B0 contribution to intestinal absorption of these substrates will
be relatively small. System B0 (SLC6A19) activity is reduced as
extracellular pH is acidified as observed in rabbit ileum and
B0AT1-expressing oocytes [155,157,158].
7.4. A potential fourth transporter of imino acids: TauT
A fourth potential transporter of imino acids in the small
intestine is the taurine transporter TauT. A high affinity
transporter for taurine was identified in the small intestine by
measurements of uptake into jejunal BBMV prepared from both
rat and rabbit [159,160]. This high affinity, low capacity, Na+
and Cl−-dependent transporter has a preference for taurine and
β-alanine with a Km for taurine of 5–40 μM. Related cDNAs
have been isolated from MDCK cells [161], rat brain [162],
mouse brain [163], and human thyroid and placenta [164,165]
and a full-length transcript has been detected in canine ileum
[161]. TauT corresponds to the 6th member of solute carrier
family 6 or SLC6A6. Functional TauT activity has been
demonstrated in human intestinal Caco-2 cell monolayers
[166,167]. The physiological role of TauT is probably to
mediate high affinity uptake of taurine during the fasting state
(such as that released from sloughed villus cells) whereas the
high capacity absorption of taurine from diet will be mediated
by the imino acid carrier PAT1. We are unaware of any
demonstration of imino acid (e.g. proline) transport via a TauT
clone although proline can inhibit TauT-mediated taurine uptake
but with relative (to taurine) low affinity [165]. A combination
of the low capacity of the TauT transporter and the relative lowaffinity for proline mean that TauT is unlikely to play a sig-
nificant role in imino acid absorption across the small intestinal
epithelium.
8. Deciphering the mechanisms of imino (and amino) acid
transport in the human small intestine
In this review we have assessed evidence primarily for two
distinct imino and amino acid transporters: the H+-coupled,
Cl−-independent, imino acid carrier (PAT1/SLC36A1, which
in intact epithelia functions in tandem with NHE3/SLC9A3)
and the Na+ and Cl−-dependent IMINO transporter (SIT1/
XT3s1/SLC6A20) [22,23,26,140,152,153]. Evidence for the
function of the imino acid carrier in the rat small intestine and
the IMINO transporter in the hamster, rabbit and guinea pig
small intestine has been available from the early 1960s onwards
[36,37,42,49,64,69,75,76]. Surprisingly we are no nearer to
understanding which of these transport systems, either or both,
functions in the human small intestine. A body of evidence
produced by a number of groups has identified functional
expression of the imino acid carrier PAT1 (SLC36A1) at the
brush-border of the human intestinal cell line Caco-2
[23,26,45,47,56,107–114,115,116,168]. The original demon-
stration of pH-dependent, Na+-independent, proline uptake
across the apical membrane of Caco-2 cells was made by
Nicklin et al. [168] but unfortunately the significance of the
observation was overlooked, probably due to the dominant Na+-
coupled dogma in the literature, and, therefore, the study
focused on the sub-maximal uptake at pH 7.4 which was
incorrectly attributed to system A (which is localised solely to
the basolateral membrane) [64,65,78]. H+-coupled, pH-depen-
dent, amino and imino acid uptake across the apical membrane
of Caco-2 cell monolayers has been demonstrated for a number
of imino acid carrier substrates [23,26,45,47,56,107–116].
Similar functional characteristics (ion coupling and substrate
specificity) have been demonstrated at the mucosal surface of
the rat small intestine [26,37–44,61,62,79,81,128]. Immunolo-
calisation of PAT1 (SLC36A1) to the brush-border membrane
of human Caco-2 cell monolayers, and human and rat small
intestine support a role for the imino acid carrier in the human
small intestine [26].
There are no studies reporting an imino acid carrier-like
transport system using human intestinal BBMV but there are
relatively few reports of studies using human intestinal BBMV
in total and, as described above, it is highly unlikely that anyone
will have performed experiments aimed at identifying a pH-
dependent, Na+-independent, transport system since such a
transport system is hardly mentioned in the literature over recent
years (Section 4.4) [65,84–90]. In a single study, Munck [169]
measured amino and imino acid uptake into human duodenal
mucosal biopsies. Proline uptake was only partially Na+-
dependent and was Cl−-independent, characteristics consistent
with imino acid carrier-like function in the rat small intestine
[79,81]. In addition uptake of the other imino acid carrier
substrates MeAIB, β-alanine, taurine and glycine was much
less sensitive to removal of extracellular Cl− than Na+ [169].
Munck made several conclusions: that the apparent lack of
192 D.T. Thwaites, C.M.H. Anderson / Biochimica et Biophysica Acta 1768 (2007) 179–197sensitivity to extracellular Cl− was due to residual Cl− trapped
within the tissues; that the observations provided evidence for a
number of Cl−-dependent transporters in human small intestine;
that the similarity in expression of Cl−-dependent carriers with
observations made in rabbit and guinea pig small intestine
suggested that the rat was not a good model for studies of the
human small intestine. However, we feel that the observations
are inconclusive and equally valid conclusions could be that: the
apparent lack of sensitivity to extracellular Cl− could be due to
uptake being a function of a mixture of both Cl−-dependent
transporters (e.g. IMINO, TauT) as well as a Cl−-independent
imino acid carrier; the similarity in imino acid carrier-like
function in human duodenum and rat small intestine suggest
that the rat is a good model for studies of the human small
intestine. Thus the results from this study using human
duodenal tissue [169] could be interpreted to support expression
of an imino acid carrier (PAT1/SLC36A1), IMINO transporter
(SLC6A20) or both.
In contrast to the comprehensive Caco-2 studies described
above [23,26,45,47,56,107–116], a single study [170] failed to
demonstrate pH-dependent imino acid uptake across the apical
membrane of Caco-2 cells and attributed proline uptake to the
IMINO transporter. There may be many reasons why pH-
dependent transport was not observed in this study [170] since
the Caco-2 cell monolayers were prepared and experiments
performed under different conditions to those in the other
studies [23,26,45,47,56,107–116,170]. For example, proline
accumulation within the Caco-2 cells was measured over 3 h
which would represent movement through a combination of
influx and efflux pathways across both apical and basolateral
cell membranes rather than the function of a single transport
system [170]. In addition the Na+-dependence of proline uptake
at apical pH 7.4 could be due to NHE3 inhibition, and
competition experiments were performed using concentrations
below the Km for most imino acid carrier/system PAT (PAT1/
SLC36A1) substrates.
Studies measuring proline uptake into human intestinal
BBMV [171,172] are often quoted as providing evidence for
the IMINO transporter although the evidence is not
convincing. In both studies there was only a small increase
in proline uptake in the presence of Na+, there was no Na+-
dependent overshoot and the observations were not con-
firmed by competition experiments [171,172]. Indeed in
human foetal small intestinal BBMV both Na+-dependent
and Na+-independent proline uptake was observed suggest-
ing that a Na+-independent carrier was also involved in
uptake [172]. More convincing evidence for the presence of
a Na+-dependent transport system for imino acids in the
human small intestine was provided in a study that described
a Na+-dependent overshoot of MeAIB in human small
intestinal BBMV, although the observations were incorrectly
attributed to system A [173]. Thus evidence exists for
expression of both imino acid carrier and IMINO transpor-
ter-like systems at the brush-border of the human small
intestine. The relative contribution of these two transport
systems to intestinal amino and imino acid absorption is
likely to vary depending upon local conditions includingsubstrate concentration and the ionic composition (Na+, Cl−
and H+) of the solution bathing the mucosal surface of the
enterocyte.
9. Conclusions
It must be emphasised that any conclusions made in a review
of this nature are made with the benefit of hindsight. It is clear
that many of the doctrines relating to intestinal amino and imino
acid absorption were based upon the observations made in a
large number of well-controlled studies. Unfortunately there has
often been as much opposing information available to render
each doctrine redundant. For one reason or another much of the
opposing information has often been omitted from key
publications so that, for example, the dogma that only L-
amino acids are absorbed has existed well beyond the date
(1959) after which there was enough evidence available to
demonstrate that it was mistaken. Many of the studies have used
tissues from different species and made measurements of
amino/imino acid transport using different techniques. It is
important that we are fully aware of the limitations of
observations made using one single technique or those using
one tissue or model system. Many of the individual studies
include inconsistencies or apparent controversial observations
or artefacts or errors but when a group of studies in any species
is reviewed an inclusive pattern of function becomes apparent.
No single study is conclusive but rather each body of evidence
produced identifies the existence of one transporter or another.
There can be no doubt that there are species differences in the
levels of expression of individual amino and imino acid
transport systems in the small intestine. It is not the intention
of this review to exclude any particular transport system for a
role in absorption in the small intestine of any particular species
but rather to highlight distinct characteristics of different
transporters and species differences in functional measure-
ments. It may be that both imino acid carrier (SLC36A1) and
IMINO (SLC6A20) like transporters are expressed in the
intestines of all species but that the absolute levels of expression
relative to each other differ between species so that only a
dominant, or highly expressed, transport system is detected. In
the human small intestine the bulk of the information favours
expression of an imino acid carrier (SLC36A1) but an IMINO
(SLC6A20) transporter may also be expressed and the relative
expression levels may vary spatially (along the length of the
small intestine and crypt-villus axis), developmentally and in
response to changes in diet, hormonal levels or pharmacological
regimes. A role for an imino acid carrier such as SLC36A1 in
absorption across the human small intestine is supported by the
large number of SLC36A1 substrates that are orally-delivered
drugs with high levels of oral bioavailability (e.g. vigabatrin)
[116,122]. It is essential that any future study of neutral imino/
amino acid and related drug absorption in the mammalian small
intestine is designed to discriminate clearly between transport
systems with overlapping function. Ultimately, understanding
the mechanisms involved in absorption across the human small
intestine will be of greatest value. However, an appreciation of
earlier work performed using various species, and in particular
193D.T. Thwaites, C.M.H. Anderson / Biochimica et Biophysica Acta 1768 (2007) 179–197species differences, will be vital to inform future studies
including those using transgenic animal models.
10. Epilogue: What's in a name? You say IMINO, I say
imino
Finally, it is clear that part of the reason that the SLC36A1
(PAT1/system PAT/imino acid carrier) transporter is not well
known, despite being identified functionally in 1964, is due to
the confusion over names. Most reports have simply ignored all
evidence for the imino acid carrier and used the IMINO term
only. As this became more prevalent, Munck and Munck started
to use both terms whilst identifying clearly which transporter
was being described by indication of the species under
investigation [80,92] (Table 1). When the human SLC36A1
transporter hPAT1 was isolated, this convention was followed
and highlighted the similarities between hPAT1/SLC36A1 and
the rat IMINO transporter (the term used to describe imino acid
carrier-like function) while identifying that the rabbit IMINO
transporter (the term used to describe IMINO-like activity) was
distinct [23]. In the following paper, the clear distinction
between the imino acid carrier and IMINO transporters was
discussed in detail [26]. It has become apparent that such
discriminations [23,26,80,92] are probably too subtle for some
and can lead to further confusion [152]. Thus the confusion over
transporter names can often reinforce dogma. Confusion can
occur not only within research fields but also between them. For
example, the anion exchanger SLC26A6 or CFEX (for
chloride–formate exchanger) [174] is also known as the
putative anion transporter (and thus PAT1) [175]. Overall the
confusion over the last 40 years informs us that complete
agreement on transporter names is unlikely to occur. However,
in the future, as long as each transporter is also identified (in
publication titles and/or abstracts) by its solute carrier family
name (using the nomenclature of the Human Genome
Organisation (HUGO) Nomenclature Committee Database;
see http://www.gene.ucl.ac.uk/nomenclature/) [176] then
further confusion and room for misinterpretation will be
diminished.
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